Eversept Partners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Eversept Partners’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-93,280	Closed	-$3.51M	–	115
2021 Q1	$3.51M	Sell	93,280 -115,875	-55%	-$2.89M	0.26%	53
2020 Q4	$3.56M	Buy	+209,155	New	+$2.62M	0.42%	38

Eversept Partners's FPRX Position: Q2 2021 in Review

Eversept Partners sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 93,280 shares — an estimated $3.51M sold.

Eversept Partners first reported a position in FPRX in Q4 2020 and held it in 2 quarters. The position peaked at $3.56M in Q4 2020. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Eversept Partners reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Eversept Partners sold 93,280 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $3.51M.
Eversept Partners first reported a position in Five Prime Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
Eversept Partners's Five Prime Therapeutics, Inc. position peaked at $3.56M in Q4 2020.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Eversept Partners's 13F filing for Q2 2021, filed 16 Aug 2021.